Omada Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 5, 2026
Rhea-AI Summary
Omada Health (Nasdaq: OMDA) will release its fourth quarter and full year 2025 financial results on Thursday, March 5, 2026 after market close and host a conference call the same day at 4:30 pm ET. A live audio webcast and replay will be available at the company's investor site for about 12 months.
Positive
- None.
Negative
- None.
News Market Reaction – OMDA
On the day this news was published, OMDA declined 2.15%, reflecting a moderate negative market reaction. Argus tracked a trough of -3.8% from its starting point during tracking. Our momentum scanner triggered 15 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $14M from the company's valuation, bringing the market cap to $644M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
OMDA is down 2.8% while peers show mixed moves: TDOC and GDRX are up 5.7% and 6.55%, SDGR up 2.51%, and OMCL and PHR down 3.74% and 3.17%, suggesting stock-specific factors rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Preliminary results | Positive | +4.6% | Preliminary Q4 and FY2025 revenue showed ~50% year-over-year growth. |
| Jan 08 | Clinical data update | Positive | -0.8% | GLP-1 companion analysis showed durable long-term weight loss and higher persistence. |
| Dec 22 | Conference participation | Neutral | +6.8% | Planned presentation at the 44th J.P. Morgan Healthcare Conference with webcast access. |
| Nov 20 | Conference participation | Neutral | -4.9% | Announcement of participation and fireside chat at Evercore Healthcare Conference. |
| Nov 06 | Quarterly earnings | Positive | -6.1% | Q3 2025 results with strong revenue growth, improved margins, and first positive EBITDA. |
Recent positive fundamentals and data updates have often seen mixed or negative next-day price reactions, especially around earnings and clinical or conference-related news.
Over the past few months, OMDA highlighted strong growth and operational progress. On Nov 6, 2025, Q3 2025 results showed higher revenue, improved margins, and first positive adjusted EBITDA, yet shares fell. Subsequent conference participation in Nov and Dec 2025 produced volatile, mixed reactions. Preliminary Q4 and FY2025 revenue released on Jan 12, 2026 drove a 4.61% gain. Today’s earnings date announcement on Mar 5, 2026 follows these earlier preliminary figures.
Market Pulse Summary
This announcement schedules Omada Health’s Q4 and full-year 2025 results release and conference call for March 5, 2026. Investors already have preliminary revenue figures from January, so this event will finalize audited numbers and provide management commentary. Recent history shows mixed price reactions to conferences and earnings. Attention will likely focus on how final results compare to the earlier preliminary ranges and prior guidance, as well as any updated outlook.
AI-generated analysis. Not financial advice.
SAN FRANCISCO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its fourth quarter and full year 2025 results on Thursday, March 5, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day.
Conference Call Details
A live audio webcast of the call will be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same link and will remain accessible for approximately 12 months.
Those participating via conference call can pre-register using the following link:
https://register-conf.media-server.com/register/BI58c6d7a71730445093f7ea7c02d33e97
About Omada Health
Omada Health (Nasdaq: OMDA) is on a mission to fix what’s broken in chronic care. Today's healthcare system poorly serves chronic conditions that require ongoing support between doctor visits, like obesity, diabetes, hypertension, and musculoskeletal disorders. Omada’s virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada has served more than one million members since launch across 2,000+ employers, health plans, and health systems. Learn more at omadahealth.com.
Contacts
Allan Kells
IR@omadahealth.com
Rose Ramseth
press@omadahealth.com
FAQ
When will Omada Health (OMDA) release Q4 and full year 2025 results?
What time is the Omada Health (OMDA) conference call on March 5, 2026?
Where can investors access the Omada Health (OMDA) earnings webcast and replay?
Can I join the Omada Health (OMDA) conference call by phone and preregister?
How long will the Omada Health (OMDA) earnings replay remain available online?
